It has previously been shown that suppressing both MAPK pathways contributed to the amelioration of chemically induced murine colitis and the restoration of the intestinal barrier by elevating tight junction expression (CLDN1, ZO-1, OCLN) [56,57]. The gene discussed is CLDN1; the disease is colitis.